The impact from NELM on the Indian pharmaceutical sector is estimated to be around Rs 6,000 crore.
Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.
What has really alarmed the police, and also the families of young drug abusers, is the entry of "chitta" -- a highly refined white powdery semi-synthetic substance (mainly heroine) -- into the drug scene and has spread like wildfire among the state's youth. Ashwani Sharma reports.
Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.
When BJP leaders, including Mr Modi's number two, Amit Shah, use the pandemic to launch an assault on state governments run by opposition parties, or to topple them, they are exploiting a grave crisis in cynical political self-interest, notes Shekhar Gupta.
Advertising agencies admitted that conversations had begun with their clients to exercise restraint while using brand endorsements featuring film actors whose names appeared in the probe.
India's COVID-19 cases and deaths per million population are amongst the lowest in the world, the govt says.
This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.
According to officials, an additional dose of vaccine is different from a booster dose.
Joshi said the international community must have a policy of zero tolerance towards terrorism and "towards those who aid and abet terrorist acts and provide safe havens to their perpetrators".
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
'Lifestyle, peer pressure, lure of extra pocket money and many other factors are responsible why youth are taking drugs.'
Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.
Prime Minister Narendra Modi is likely to announce a host of initiatives for the health sector on Independence Day with the highlights being the 'Heal in India' and 'Heal by India' projects and a roadmap to eliminate sickle cell disease by 2047, official sources said.
In a joint statement posted on their respective twitter accounts, the companies said Serum Institute Chief Executive Officer Adar Poonawalla and Bharat Biotech Chairman Krishna Ella communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
National security advisor Ajit Doval on Friday suggested that various central armed police forces of the country should have "jointness" and interoperability among themselves like the ongoing plan for the defence forces.
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions.
Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, 'manufacture and distribution', failing which legal action would be taken.
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.
'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'
'You ain't seen anything yet,' EAM Jaishankar says about the India-US relationship.
He explained, "Children between the age of 12 and 18 years, particularly those in the age group of 15 to 18 years, are very much like adults. Our research within the country also says that almost two-thirds of the deaths below 18 years which occurred due to COVID in India are within this age group. So, this decision was mainly taken to protect the adolescents."
Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.
This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country.
Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the "single dose infusion-based treatment" on Tuesday and then kept under observation.
'This government did not have any plan for safety stocks of essential medicines.'
The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.
'An entire operation was running systematically prior to the revoking of Article 370.'
Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.
In Jaipur, the combination of lopinavir and ritonavir, both second-line HIV drugs, was administered was administered on an elderly Italian couple undergoing treatment for Covid-19 at the SMS Hospital.
The EC said that the data should be deleted by health authorities once the vaccination exercise concludes.
The senior officials of the health ministry apprised the minister on various improvements that have been made to make the pan India dry run glitch free, such as number of telephone operators has been increased to answer every possible query from the teams on the ground conducting the dry run.
There are a number of trial sites across both Mumbai and Pune that we have shortlisted, as these cities have many hotspots, which will help us understand the efficacy of the vaccine, the company's chief executive Adar Poonawalla said.
Security agencies could track the flight path and even address of criminals involved in this cross-border illegal activity that is rearing its head over the last few years, he said on Saturday.
Poonawalla, during an interaction with Odisha Chief Minister Naveen Patnaik through a video conference, expressed optimism that the COVID-19 vaccine could be ready by October-November this year and the next phase of the trial can start in mid-August in India. According to a press note released by the CMO, Poonawalla has informed that the Oxford University vaccine has shown promising results in the first phase trial.
ICMR says it is following all globally accepted norms to fast-track vaccine and wants to 'cut red tape'.
'In our country, there is a lot of checks and balances, the figures cannot go wrong.' 'Because they are being checked by not only the governments, but by doctors themselves.'
